Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 87Glioblastoma 85Sarcoma 82Central Nervous System Neoplasms 50Dendritic Cell Sarcoma, Interdigitating 33Lymphoma 31Burkitt Lymphoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Non-Hodgkin 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, Large B-Cell, Diffuse 26Leukemia 26Lymphoma, Follicular 24Lymphoma, Mantle-Cell 23Myelodysplastic Syndromes 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Chronic-Phase 21Recurrence 20Astrocytoma 20Leukemia, Myeloid, Accelerated Phase 19Hodgkin Disease 19Blast Crisis 18Multiple Myeloma 17Leukemia, Myeloid, Acute 17Liposarcoma 16Glioma 16Rhabdomyosarcoma 15Neoplasms, Plasma Cell 15Brain Neoplasms 14

Interventions

Radiotherapy 1Methylphenidate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Radiotherapy × Sarcoma × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡